Medical combinations comprising tiotropium and rofleponide
OwnerBrian Charles Gavininventor
Life of this patent
Estimating the term…
Abstract
The present invention is concerned with pharmaceutical formulations comprising a combination of tiotropium and rofleponide and the use of such formulations in medicine, particularly in the prophylaxis and treatment of respiratory diseases.
Claims8
A pharmaceutical formulation comprising tiotropium or a pharmaceutically acceptable salt, solvate, or physiologically functional derivative thereof and rofleponide or a pharmaceutically acceptable salt, solvate, or physiologically functional derivative thereof, and a pharmaceutically acceptable carrier or excipient, and optionally one or more other therapeutic ingredients.
A pharmaceutical formulation comprising tiotropium bromide and rofleponide, and a pharmaceutically acceptable carrier or excipient, and optionally one or more other therapeutic ingredients.
A pharmaceutical formulation comprising tiotropium bromide and rofleponide palmitate, and a pharmaceutically acceptable carrier or excipient, and optionally one or more other therapeutic ingredients.
A method for the prophylaxis or treatment of a clinical condition in a mammal, such as a human, for which an anticholinergic agent and/or antiinflammatory corticosteroid is indicated, which comprises administration of a therapeutically effective amount of a pharmaceutical formulation according to any one of claims 1 to 37
Dependencies are inferred from the claim text.